Lesson 7 — Who Does What? Why? Who Pays?
What Is Evolution Really?
Learning Material
1 pagesLesson 7 — Who Does What? Why? Who Pays?
Understanding the Complex: What Is Evolution Really?
Evolutionary biology is one of the most globally dispersed scientific disciplines. Its raw materials — organisms, fossils, DNA — are distributed across every ecosystem and every museum on earth, and the questions it asks are broad enough to draw researchers from genetics, paleontology, ecology, anthropology, computer science, and medicine. Understanding who does this work, where, and with what motivation helps demystify how science actually operates.
The research institutions
The Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany, is one of the world's leading centers for human evolutionary biology. It's where Svante Pääbo built the paleogenomics laboratory that sequenced the Neanderthal and Denisovan genomes. The institute brings together linguists, primatologists, social anthropologists, and geneticists — the logic being that human evolution encompasses biology, behavior, and culture together.
The Max Planck Institute for Evolutionary Biology in Plön — a small town in northern Germany — focuses on the genetics and theory of evolution itself: how populations evolve, how genomes change, how parasites and hosts coevolve. It was founded in 1936, was embroiled in controversy during the Nazi period (it was used to pursue pseudoscientific racial biology), and was reconstituted after the war under the name by which it's now known. That history is a reminder that evolutionary biology, like any science, is conducted by humans in historical contexts, and can be distorted by ideological pressure.
In the United States, evolutionary biology is distributed across university departments of biology, anthropology, and medicine, with major centers at Harvard, Berkeley, MIT, and Michigan State (where Lenski's lab operates). The National Institutes of Health and the National Science Foundation are the primary funders. In the United Kingdom, the Natural History Museum in London is a major hub — it holds one of the largest biological collections in the world, with 80 million specimens including Darwin's own collections from the Beagle voyage.
Museums as scientific infrastructure
Natural history museums are often perceived as public attractions — for school trips and weekend outings. They are that, but they're also something more: irreplaceable scientific archives.
The collections at the Natural History Museum London, the Smithsonian in Washington, the American Museum of Natural History in New York, and their counterparts in Paris, Berlin, and Vienna contain specimens collected over centuries. These collections are the raw material for comparative studies — for answering questions like "how has the body size of this bird species changed over the last hundred years?" or "what were the disease patterns of ancient populations?" The specimens weren't collected with those questions in mind; they were collected opportunistically, often by Victorian-era naturalists whose methods we'd now consider inadequate. But they're what we have, and their value compounds as new analytical methods are developed.
Digitization of museum collections — making specimen records and images accessible to researchers worldwide — is one of the major infrastructure investments in contemporary biology. The Global Biodiversity Information Facility aggregates over two billion occurrence records from institutions in 50 countries.
Funding and the peer-review system
Evolutionary research, like most basic science, is funded primarily by governments through research councils and agencies, with additional contributions from private foundations. The Howard Hughes Medical Institute in the United States funds evolutionary work, as do the Wellcome Trust and the European Research Council.
A consistent tension in science funding is between basic and applied research. Evolutionary biology has historically been classified as basic — curiosity-driven research without immediate application. But the practical payoffs have been substantial: directed evolution techniques, developed partly from understanding natural evolution, are now used to engineer proteins with desired properties. Evolutionary algorithms model evolutionary processes in software to solve optimization problems. The antibiotic development pipeline explicitly considers evolutionary resistance dynamics.
Research results are validated through peer review — submission to a journal, evaluation by other scientists in the field, revision based on feedback, and publication if the work meets the standard. It's imperfect — reviewers can be biased, important work can be slow to gain acceptance, and the pressure to publish can incentivize overstatement. But it's the best system anyone has developed for collectively verifying and accumulating knowledge.
Evolution in practice: medicine, agriculture, technology
The most direct application of evolutionary thinking in medicine is in infectious disease. Epidemiologists track the evolution of pathogens in real time, sequencing viral or bacterial genomes as they circulate through populations, identifying which variants are spreading and why. This practice — pathogen genomic surveillance — became mainstream during COVID-19 and is now established infrastructure for future pandemic preparedness.
In agriculture, understanding how crop diseases evolve has become essential for managing them. Plant pathologists track the evolution of rust fungi and other crop pathogens, developing new resistant varieties before the pathogens evolve past existing defenses — an evolutionary arms race being managed in real time.
Directed evolution, developed by Frances Arnold (Nobel Prize in Chemistry, 2018), uses artificial selection to evolve proteins and enzymes with specific industrial or pharmaceutical properties. The process mirrors natural evolution deliberately: generate variation (through mutagenesis), select for desired function, repeat. The resulting molecules couldn't be designed from scratch because they depend on configurations that are only discoverable through evolutionary search.
Evolutionary biology is not ivory-tower speculation. Its practitioners are distributed across museums, universities, and biotechnology companies on every continent, funded by governments and foundations, doing work with direct consequences for medicine, agriculture, and technology. Understanding that infrastructure — who funds it, who does it, what pressures they operate under — is part of understanding the science.
Next lesson: What's contested — the genuine disputes within evolutionary biology, and the questions that sit at the boundary of science.
Reading time: approx. 9–10 minutes